FENC (Biotechnology) Stock Valuation & Fair Value Quality business with a solid forward outlook
FENC (Biotechnology) trades at a blended P/E of 4,547.8, in line with its historical valuation, with a forward growth estimate of 1,322.8% and a PEG of 3.44. Analysts' one-year estimates have been hit 29% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is FENC overvalued?
At a blended P/E of 4,547.8, FENC is broadly in line with its historical valuation, with a PEG of 3.44 on 1,322.8% forward growth. tickerseer currently rates it quality business with a solid forward outlook.
What is FENC's fair value and PEG?
FENC trades at a blended P/E of 4,547.8, a PEG of 3.44, and a forward growth estimate of 1,322.8%.
Has tickerseer's rating of FENC changed?
tickerseer's rating has been quality business with a solid forward outlook since 2026-08-07.
Industry: Biotechnology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.